ClinicalTrials.Veeva

Menu

MiGo Tracker Remote Monitoring of Home Exercise After Stroke

F

Flint Rehabilitation Devices

Status

Enrolling

Conditions

Subacute Stroke

Treatments

Other: Conventional home exercise program
Device: MiGo Tracker

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT06752707
R44AG090216-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Experienced one or more strokes less than one month (30 days) prior
  • Upper Extremity Fugl-Meyer Score > 5 and <= 55 out of 66
  • Absence of moderate to severe pain (<= 4 on the 10 point visual-analog pain scale)

Exclusion criteria

  • age <18 years old
  • Unable to follow 2-step commands
  • Other neurological diagnosis (e.g. Parkinson's Disease)
  • Other severe concurrent medical conditions that may prevent the participants from completing the 3-month study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

MiGo Tracker enabled RTM Program
Experimental group
Description:
Participants will be provided a MiGo Tracker device which will log all home exercise sessions and uploaded to the MiGo-RTM dashboard. The supervising study therapist will conduct weekly phone calls with each participant where they review exercise metrics and assist with any barriers or issues.
Treatment:
Device: MiGo Tracker
Conventional Standard of Care
Active Comparator group
Description:
Participants will be assigned a home exercise regimen designed by a study therapist based on the individual participant's specific goals and abilities.
Treatment:
Other: Conventional home exercise program

Trial contacts and locations

1

Loading...

Central trial contact

Daniel Zondervan, PhD; Ian M Russell, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems